Arcutis Biotherapeutics Inc
ARQTHealthcare|Biotechnology|USA
$27.74
-1.03 (-3.58%)
Tangible Book
$1.40
Upcoming Data Readouts (2)
Sep 2026
Est. completion
P2Hidradenitis Suppurativa
A Study for Evaluating Safety & Efficacy of Topical Roflumilast 0.3% Foam in Hidradenitis Suppurativa
NCT07077902n=10
Apr 2028
Est. completion
P1Atopic Dermatitis (AD)
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
NCT07453602n=125